✦ LIBER ✦

Serous tumours of low malignant potential (serous borderline tumours): moving toward détente

✍ Scribed by T A Longacre; R L Kempson; M R Hendrickson

Book ID: 108779946
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 58 KB
Volume: 47
Category: Article
ISSN: 0309-0167
DOI: 10.1111/j.1365-2559.2005.02185.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathology of borderline (low malignant p

Pathology of borderline (low malignant potential) ovarian tumours

✍ Jeffrey D Seidman; Brigitte M Ronnett; Robert J Kurman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Possible Metaplastic Origin of Lymph Nod

Possible Metaplastic Origin of Lymph Node “Metastases” in Serous Ovarian Tumor of Low Malignant Potential (Borderline Serous Tumor)

✍ Nicholas Kadar; Martin Krumerman 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 372 KB

Morphometry and digital AgNOR analysis i

Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours

✍ S. Štemberger-Papić; T. Stanković; D. Vrdoljak-Mozetič; D. Verša-Ostojić; M. Kra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

Ovarian papillary serous tumors of low m

Ovarian papillary serous tumors of low malignant potential (Serous borderline tumors): A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma

✍ Alexander W. Kennedy; William R. Hart 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

## Background: The clinical outcome of patients with ovarian serous tumors of low malignant potential (lmp) remains controversial, especially for those with extraovarian disease. we retrospectively reviewed our experience to study this question further, to assess the safety of conservative manageme